Brief: Dr. Lal Pathlabs Q3 Consol Net Profit 905 Million Rupees
30/01/2026 07:49
Jan 30 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS: DR. LAL PATHLABS Q3 CONSOL NET PROFIT 905 MILLION RUPEES DR. LAL PATHLABS Q3 CONSOL REVENUE FROM OPERATIONS 6.60 BILLION RUPEES DR LAL PATHLABS LTD - DECLARATION OF INTERIM DIVIDEND OF 3.5 RUPEES PER EQUITY SHARE Source text: ID:nnAZN4S6CPF Further company coverage: DLPA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise